Jump to: What Kind Patches claims to do | The science behind transdermal delivery | Ingredient analysis | Why GLP-1 patches is misleading | Cost and value assessment | UK regulatory concerns | Evidence-based alternatives | Take home message There is no evidence that Kind Patches work to support weight loss
These medications appear to reduce the production of pro-inflammatory cytokinessignalling molecules that drive inflammationsuch as tumour necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)
These two mechanisms support individuals living with type 2 diabetes in managing their blood glucose levels on a meal-to-meal basis
Published research of our programme in JMIR Formative Research reports an average weight loss of 19.1% at 12 months with semaglutide and behavioural support
Multifunctional theranostic constructs co-encapsulate imaging probes with therapeutics, permitting real-time monitoring of biodistribution and receptor engagement
Journal of Pediatric Endocrinology and Metabolism , 22(11), 10531061